Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Harmke J. Groot"'
Autor:
Sjoukje Lubberts, Harmke J. Groot, Ronald de Wit, Sasja Mulder, Johannes A. Witjes, J. Martijn Kerst, Gerard Groenewegen, Joop D. Lefrandt, Flora E. van Leeuwen, Janine Nuver, Michael Schaapveld, Jourik A. Gietema
Publikováno v:
Journal of Clinical Oncology, 41, 19, pp. 3512-3522
PURPOSE Testicular cancer (TC) treatment is clearly associated with cardiovascular morbidity and mortality. To enable development of preventive strategies for cardiovascular disease (CVD), we assessed cardiometabolic risk factors and quality of life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bce1af2304f7ae8686760e46080c292
https://repository.ubn.ru.nl/handle/2066/294345
https://repository.ubn.ru.nl/handle/2066/294345
Autor:
Eline H. Huele, Maureen J.B. Aarts, Jacqueline M. Tromp, Michael Schaapveld, Ronald de Wit, Hetty A van den Berg, J. Alfred Witjes, Jourik A. Gietema, Tineke J. Smilde, Harmke J. Groot, Ben G. L. Vanneste, Gerard Groenewegen, J.L.H. Ruud Bosch, Janine Nuver, Simon Horenblas, Richard P. Meijer, Peter De Brouwer, Joost M. Blok
Publikováno v:
Journal of Clinical Oncology, 39, 4, pp. 319-327
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4):JCO2002352, 319-330. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 39(4), 319-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 319-327
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4):JCO2002352, 319-330. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 39(4), 319-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 319-327
PURPOSE Patients with testicular germ cell tumor (TGCT) are at increased risk of developing a contralateral TGCT (CTGCT). Although some studies suggest that prior treatment with platinum-based chemotherapy affects CTGCT risk, a relationship between C
Autor:
Peter De Brouwer, Gerard Groenewegen, Richard P. Meijer, Janine Nuver, Harmke J. Groot, Joost M. Blok, Jourik A. Gietema, Ruud Bosch, Ronald de Wit, Hetty A van den Berg, Jacqueline M. Tromp, Alfred Witjes, Maureen J.B. Aarts, Tineke J. Smilde, Michael Schaapveld, Simon Horenblas, Ben G. L. Vanneste
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Patients with testicular germ cell tumor (TGCT) are at increased risk of developing a metachronous contralateral testicular germ cell tumor (CTGCT). It is unclear whether...
Autor:
Ronald de Wit, Sjoukje Lubberts, Michael Schaapveld, O. W. M. Meijer, Simon Horenblas, Igle J. de Jong, Tineke J. Smilde, Alexandra W. van den Belt-Dusebout, Jourik A. Gietema, Hetty A van den Berg, Ben G. L. Vanneste, Gerard Groenewegen, Maarten C.C.M. Hulshof, Maureen J.B. Aarts, Harmke J. Groot, Katarzyna Jóźwiak, Philip Poortmans, J. Alfred Witjes, Flora E. van Leeuwen
Publikováno v:
Cancer, 126(3), 628-639. Wiley
Cancer, 126(3), 628-639. John Wiley and Sons Inc.
Cancer, 126, 628-639
Groot, H J, van Leeuwen, F E, Lubberts, S, Horenblas, S, de Wit, R, Witjes, J A, Groenewegen, G, Poortmans, P M, Hulshof, M C C M, Meijer, O W M, de Jong, I J, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J B, Jóźwiak, K, van den Belt-Dusebout, A W, Gietema, J A & Schaapveld, M 2020, ' Platinum exposure and cause-specific mortality among patients with testicular cancer ', Cancer, vol. 126, no. 3, pp. 628-639 . https://doi.org/10.1002/cncr.32538
Cancer, 126(3), 628. John Wiley and Sons Inc.
Cancer, 126, 3, pp. 628-639
Cancer, 126, 628-639. John Wiley & Sons Inc.
Cancer
Cancer, 126(3), 628-639. John Wiley and Sons Inc.
Cancer, 126, 628-639
Groot, H J, van Leeuwen, F E, Lubberts, S, Horenblas, S, de Wit, R, Witjes, J A, Groenewegen, G, Poortmans, P M, Hulshof, M C C M, Meijer, O W M, de Jong, I J, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J B, Jóźwiak, K, van den Belt-Dusebout, A W, Gietema, J A & Schaapveld, M 2020, ' Platinum exposure and cause-specific mortality among patients with testicular cancer ', Cancer, vol. 126, no. 3, pp. 628-639 . https://doi.org/10.1002/cncr.32538
Cancer, 126(3), 628. John Wiley and Sons Inc.
Cancer, 126, 3, pp. 628-639
Cancer, 126, 628-639. John Wiley & Sons Inc.
Cancer
Background Although testicular cancer (TC) treatment has been associated with severe late morbidities, including second malignant neoplasms (SMNs) and ischemic heart disease (IHD), cause‐specific excess mortality has been rarely studied among patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e91b836123a14cbb96ff238908c8cb
https://cris.maastrichtuniversity.nl/en/publications/93b4dad2-5b86-489e-9df0-7b83bbf501c0
https://cris.maastrichtuniversity.nl/en/publications/93b4dad2-5b86-489e-9df0-7b83bbf501c0
Autor:
Richard P. Meijer, Janine Nuver, Gerard Groenewegen, Maureen J.B. Aarts, Jacqueline M. Tromp, Tineke J. Smilde, Harmke J. Groot, P.J.M. De Brouwer, Eline H. Huele, Ben G. L. Vanneste, H.A. Van Den Berg, S. Horenblas, J.A. Witjes, J.L.H.R. Bosch, J.M. Blok, Michael Schaapveld, R. de Wit, Jourik A. Gietema
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e405-e406 (2020)
Autor:
Ben G. L. Vanneste, Fred Witjes, Ronald de Wit, Janine Nuver, Maureen J.B. Aarts, Jacqueline M. Tromp, Richard P. Meijer, Eline H. Huele, Ruud Bosch, Simon Horenblas, Harmke J. Groot, Peter De Brouwer, Tineke J. Smilde, Gerard Groenewegen, Jourik A. Gietema, J.M. Blok, Michael Schaapveld, Hetty A van den Berg
Publikováno v:
Journal of Clinical Oncology, 38(6). AMER SOC CLINICAL ONCOLOGY
419 Background: Patients with testicular germ cell tumor (TGCT) are at increased risk of developing a metachronous contralateral testicular tumor (CLTT). It is unclear whether the histology of the primary tumor and treatment with platinum-based chemo
Autor:
Peter De Brouwer, Ben G. L. Vanneste, Flora E. van Leeuwen, J. Martijn Kerst, Sjoukje Lubberts, Alphonsus C. M. van den Bergh, Tineke J. Smilde, J. Alfred Witjes, Jourik A. Gietema, Berthe M.P. Aleman, Maureen J.B. Aarts, O. W. M. Meijer, Maarten C.C.M. Hulshof, Gerard Groenewegen, Simon Horenblas, Ronald de Wit, Katarzina Jóźwiak, Michael Schaapveld, Luca Incrocci, Hetty A van den Berg, Harmke J. Groot, Alexandra W. van den Belt-Dusebout
Publikováno v:
Groot, H J, Gietema, J A, Aleman, B M P, Incrocci, L, de Wit, R, Witjes, J A, Groenewegen, G, de Brouwer, P, Meijer, O W M, Hulshof, M C C M, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J, van den Bergh, A C M, Kerst, J M, van den Belt-Dusebout, A W, Lubberts, S, Jóźwiak, K, Horenblas, S, van Leeuwen, F E & Schaapveld, M 2018, ' Risk of diabetes after para-aortic radiation for testicular cancer ', British Journal of Cancer, vol. 119, no. 7, pp. 901-907 . https://doi.org/10.1038/s41416-018-0248-x
British Journal of Cancer, 119(7), 901-907. Nature Publishing Group
British journal of cancer, 119(7), 901-907. Nature Publishing Group
British Journal of Cancer, 119, 901-907
British Journal of Cancer
British Journal of Cancer, 119, 7, pp. 901-907
British Journal of Cancer, 119(7), 901-907. Nature Publishing Group
British journal of cancer, 119(7), 901-907. Nature Publishing Group
British Journal of Cancer, 119, 901-907
British Journal of Cancer
British Journal of Cancer, 119, 7, pp. 901-907
BACKGROUND: While the risk of diabetes is increased following radiation exposure to the pancreas among childhood cancer survivors, its association among testicular cancer (TC) survivors has not been investigated.METHODS: Diabetes risk was studied in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77e9f1b2251f1104f84fccbd45137d30
https://research.vumc.nl/en/publications/fbc13bdd-0cb2-436b-883c-a0a5c6311c9f
https://research.vumc.nl/en/publications/fbc13bdd-0cb2-436b-883c-a0a5c6311c9f
Autor:
Katarzyna Jóźwiak, J.M. Kerst, Hetty A van den Berg, Jourik A. Gietema, Maureen J.B. Aarts, Tineke J. Smilde, Philip Poortmans, Sjoukje Lubberts, Ben G. L. Vanneste, Alfons J.M. van den Eertwegh, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Harmke J. Groot, Heinz-Josef Klümpen, Luca Incrocci, J.A. Witjes, Ronald de Wit, Alfons C.M. van den Bergh, Flora E. van Leeuwen, Gerard Groenewegen, Michael Schaapveld, Igle J. de Jong
Publikováno v:
Groot, H J, Lubberts, S, de Wit, R, Witjes, J A, Kerst, J M, de Jong, I J, Groenewegen, G, van den Eertwegh, A J M, Poortmans, P M, Klümpen, H-J, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J, Incrocci, L, van den Bergh, A C M, Jóźwiak, K, van den Belt-Dusebout, A W, Horenblas, S, Gietema, J A, van Leeuwen, F E & Schaapveld, M 2018, ' Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era ', Journal of Clinical Oncology, vol. 36, no. 24, pp. 2504-2513 . https://doi.org/10.1200/JCO.2017.77.4174
Journal of Clinical Oncology, 36(24), 2504-2513. American Society of Clinical Oncology
Journal of Clinical Oncology, 36, 24, pp. 2504-2513
Journal of clinical oncology, 36(24), 2504-2513. American Society of Clinical Oncology
Journal of Clinical Oncology, 36, 2504-2513
Groot, H J, Lubberts, S, de Wit, R, Witjes, J A, Kerst, J M, de Jong, I J, Groenewegen, G, van den Eertwegh, A J M, Poortmans, P M, Klümpen, H J, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J, Incrocci, L, van den Bergh, A C M, Jozwiak, K, van den Belt-Dusebout, A W, Horenblas, S, Gietema, J A, van Leeuwen, F E & Schaapveld, M 2019, ' Re: Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era ', Journal of Urology, vol. 201, no. 3, pp. 445 . https://doi.org/10.1097/01.JU.0000553704.62228.49
Journal of Clinical Oncology, 36(24), 2504. American Society of Clinical Oncology
Journal of urology, 201(3). Elsevier Inc.
Journal of Urology, 201(3). LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 36(24), 2504-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 36(24), 2504-2513. AMER SOC CLINICAL ONCOLOGY
Journal of Urology, 201(3). Elsevier Inc.
Journal of Clinical Oncology, 36(24), 2504-2513. American Society of Clinical Oncology
Journal of Clinical Oncology, 36, 24, pp. 2504-2513
Journal of clinical oncology, 36(24), 2504-2513. American Society of Clinical Oncology
Journal of Clinical Oncology, 36, 2504-2513
Groot, H J, Lubberts, S, de Wit, R, Witjes, J A, Kerst, J M, de Jong, I J, Groenewegen, G, van den Eertwegh, A J M, Poortmans, P M, Klümpen, H J, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J, Incrocci, L, van den Bergh, A C M, Jozwiak, K, van den Belt-Dusebout, A W, Horenblas, S, Gietema, J A, van Leeuwen, F E & Schaapveld, M 2019, ' Re: Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era ', Journal of Urology, vol. 201, no. 3, pp. 445 . https://doi.org/10.1097/01.JU.0000553704.62228.49
Journal of Clinical Oncology, 36(24), 2504. American Society of Clinical Oncology
Journal of urology, 201(3). Elsevier Inc.
Journal of Urology, 201(3). LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 36(24), 2504-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 36(24), 2504-2513. AMER SOC CLINICAL ONCOLOGY
Journal of Urology, 201(3). Elsevier Inc.
Purpose Testicular cancer (TC) treatment increases risk of subsequent malignant neoplasms (SMNs). It is unknown whether changes in TC treatment over time have affected SMN risk. Methods Solid SMN risk was evaluated in a multicenter cohort comprising
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc2e066861126a1363b87f7f3132dfe0
https://research.vumc.nl/en/publications/89445b9c-8dcb-4f79-8ab0-cc820c765d31
https://research.vumc.nl/en/publications/89445b9c-8dcb-4f79-8ab0-cc820c765d31
Autor:
Groot HJ; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Lubberts S; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., de Wit R; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Witjes JA; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Kerst JM; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., de Jong IJ; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Groenewegen G; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., van den Eertwegh AJM; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Poortmans PM; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Klümpen HJ; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., van den Berg HA; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Smilde TJ; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Vanneste BGL; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Aarts MJ; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Incrocci L; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., van den Bergh ACM; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Jóźwiak K; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., van den Belt-Dusebout AW; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Horenblas S; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Gietema JA; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., van Leeuwen FE; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France., Schaapveld M; Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Aug 20; Vol. 36 (24), pp. 2504-2513. Date of Electronic Publication: 2018 Jul 10.